KRAS and pancreatic ductal adenocarcinoma: These results suggest that KRAS mutation likely represents an early and initiating event in human pancreatic cancer.[21] The KRAS gene was mutated in 92 % of the cases in a cohort analysis of 109 pancreatic ductal carcinomas that underwent whole‐exome sequencing.